Sleeping Bruxism Treatment Market Analysis

 Product Type (Mouth Guards, NTI-tss and Splints)

By product type, the NTI-tss and Splints segment is estimated to capture around 62.3% sleeping bruxism treatment market share by the end of 2037. The segment’s growth is due to its proven effectiveness in managing teeth grinding and jaw clenching. NTI-tss devices specifically target the trigeminal nerve to reduce muscle tension, while custom-made splints protect teeth from damage. For instance, in June 2021, Glidewell launched NTI-tss Plus and the NTI OmniSplint. These FDA-approved dental supplies can minimize clenching forces by about 70%. These treatments offer non-invasive, comfortable solutions that align with patient preferences, making them increasingly popular and driving the market demand.

Patient Type (Adult, Pediatric)

Based on patient type, the adult segment is anticipated to hold the majority sleeping bruxism treatment market share over the forecast period. The segment is growing due to increasing stress, anxiety, and lifestyle factors, such as long working hours and sleep disorders, prevalent in adult populations. According to a Sleep Foundation article, published in April 2024, bruxing is more common in younger adults who may exert around 250 pounds of pure force while grinding. In addition, 8% of middle-aged and 3% of other adults are estimated to suffer from this condition. As awareness about the harmful effects of untreated bruxism, such as tooth damage and jaw issues, rises, more adults are seeking treatment. The availability of non-invasive solutions, such as mouthguards and biofeedback devices, further contributes to the growth of sleeping bruxism treatment.

Our in-depth analysis of the global market includes the following segments: